NIAMS Clinical Research Center for Rheumatoid Disease
NIAMS 类风湿疾病临床研究中心
基本信息
- 批准号:6739023
- 负责人:
- 金额:$ 117.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-04-15 至 2008-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): The Medical University of South Carolina will establish a Multidisciplinary Clinical Research Center (MCRC) for the Study of Rheumatic Diseases in African-Americans. This MCRC will focus on scleroderma (SSc) and systemic lupus erythematosus (SLE), two rheumatic diseases that disproportionately affect the African-American community. Outstanding leadership in three key areas - Rheumatology, Biometry/Epidemiology, and Health Services Research - provides a framework for successful design and implementation of meaningful clinical research in this understudied population of patients. Three projects and three supporting cores are proposed. Project A is designed to study the interactions between TGF-beta and sphingolipid signaling pathways in SSc and normal fibroblasts. The proposed studies will elucidate this heretofore-unknown interaction to shed light on the mechanism whereby TGF-beta signaling is integrated with other cellular signaling pathways leading to fibrosis. Project B addresses an important understudied area, namely psychosocial aspects of female adolescents with SLE, the majority of whom are African-American. MCRC investigators will assess the associations between adaptational processes and adjustment and health-related quality of life, and will conduct an interventional trial designed to enhance adjustment and quality of life for these patients. Project C will address the important issue of divergent racial trends in morbidity from lupus nephritis. Mortality has increased for African-American lupus patients while remaining stable in Caucasian lupus patients, and this divergence cannot be accounted for by differences in socioeconomic status alone. Utilizing the unique resources of the Carolina Lupus Study and the sea island Gullah population, MCRC investigators will address genetic and environmental influences on the development and progression of lupus nephritis. Each of these projects, as well as future pilot projects to be developed by the MCRC, will be served by two Cores: (1) a Methodology Core will provide rigorous methodological and biostatistical support; and (2) a Patient Resource Core will assure MCRC investigators access to a population of African-American patients who are clinically well characterized and from whom biological samples are obtained and stored. This MCRC will facilitate the translation of basic research into the clinical arena, support much needed behavioral research, and conduct epidemiology and health services research on rheumatic diseases affecting minorities and women disproportionately, thus exemplifying the "cross-cutting" nature of research proposed in NIAMS's strategic plan.
描述(由申请人提供):南卡罗来纳医科大学将建立一个多学科临床研究中心(MCRC),用于研究非裔美国人的风湿性疾病。MCRC将重点关注硬皮病(SSC)和系统性红斑狼疮(SLE),这两种风湿性疾病对非裔美国人社区的影响不成比例。在风湿学、生物统计学/流行病学和卫生服务研究这三个关键领域的杰出领导地位,为在这一研究不足的患者群体中成功设计和实施有意义的临床研究提供了一个框架。提出了三个项目和三个支持核心。项目A旨在研究转化生长因子-β和鞘磷脂信号通路在SSC和正常成纤维细胞中的相互作用。拟议的研究将阐明这一迄今未知的相互作用,以阐明转化生长因子-β信号与其他细胞信号通路整合导致纤维化的机制。项目B涉及一个未得到充分研究的重要领域,即患有系统性红斑狼疮的女性青少年的心理社会问题,她们中的大多数是非洲裔美国人。MCRC调查人员将评估适应过程与适应和与健康相关的生活质量之间的联系,并将进行一项旨在提高这些患者的适应和生活质量的干预性试验。项目C将解决狼疮性肾炎发病率不同的种族趋势这一重要问题。非裔美国人狼疮患者的死亡率有所增加,而高加索人狼疮患者的死亡率保持稳定,这种差异不能仅由社会经济地位的差异来解释。利用卡罗莱纳州狼疮性肾炎研究和海岛古拉族人口的独特资源,MCRC的研究人员将研究遗传和环境对狼疮性肾炎发生和发展的影响。这些项目中的每一个,以及MCRC未来将开发的试点项目,都将由两个核心提供服务:(1)方法学核心将提供严格的方法学和生物统计学支持;(2)患者资源核心将确保MCRC调查人员接触到临床特征良好的非裔美国患者,生物样本是从他们那里获得和存储的。该MCRC将促进基础研究向临床领域的转化,支持亟需的行为研究,并对影响少数族裔和妇女的风湿病进行流行病学和卫生服务研究,从而体现NIAMS战略计划中提出的研究的“交叉”性质。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RICHARD M. SILVER其他文献
RICHARD M. SILVER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RICHARD M. SILVER', 18)}}的其他基金
Safety & Suitability of Dabigatran to Inhibit Thrombin in Scleroderma
安全
- 批准号:
8831886 - 财政年份:2015
- 资助金额:
$ 117.78万 - 项目类别:
Defective c-MET signaling in African American scleroderma patients
非裔美国硬皮病患者的 c-MET 信号传导缺陷
- 批准号:
8494003 - 财政年份:2013
- 资助金额:
$ 117.78万 - 项目类别:
Defective c-MET signaling in African American scleroderma patients
非裔美国硬皮病患者的 c-MET 信号传导缺陷
- 批准号:
8295198 - 财政年份:2012
- 资助金额:
$ 117.78万 - 项目类别:
CYCLOPHOSPHAMIDE VS PLACEBO IN SYST SCL PULM ALVEOLITIS
环磷酰胺与安慰剂治疗 SYST SCL 肺泡炎
- 批准号:
7204972 - 财政年份:2005
- 资助金额:
$ 117.78万 - 项目类别:
NIAMS Clinical Research Center for Rheumatoid Disease
NIAMS 类风湿疾病临床研究中心
- 批准号:
6851606 - 财政年份:2004
- 资助金额:
$ 117.78万 - 项目类别:
Cyclophosphamide vs. Placebo in Syst. Scl. Pulm. Alveolitis
环磷酰胺与安慰剂在系统中的比较。
- 批准号:
7043445 - 财政年份:2004
- 资助金额:
$ 117.78万 - 项目类别:
相似海外基金
FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
- 批准号:
EP/Y036395/1 - 财政年份:2024
- 资助金额:
$ 117.78万 - 项目类别:
Research Grant
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
- 批准号:
10764456 - 财政年份:2023
- 资助金额:
$ 117.78万 - 项目类别:
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 117.78万 - 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
- 批准号:
10743328 - 财政年份:2023
- 资助金额:
$ 117.78万 - 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
- 批准号:
10638813 - 财政年份:2023
- 资助金额:
$ 117.78万 - 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
- 批准号:
10823828 - 财政年份:2023
- 资助金额:
$ 117.78万 - 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
- 批准号:
10828665 - 财政年份:2023
- 资助金额:
$ 117.78万 - 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
- 批准号:
10721095 - 财政年份:2023
- 资助金额:
$ 117.78万 - 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
- 批准号:
10795328 - 财政年份:2023
- 资助金额:
$ 117.78万 - 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
- 批准号:
10828252 - 财政年份:2023
- 资助金额:
$ 117.78万 - 项目类别: